213 related articles for article (PubMed ID: 20639252)
1. Analysis of deaths occurring within the Nottingham trial of faecal occult blood screening for colorectal cancer.
Whynes DK; Mangham CM; Balfour TW; Scholefield JH
Gut; 2010 Aug; 59(8):1088-93. PubMed ID: 20639252
[TBL] [Abstract][Full Text] [Related]
2. Nottingham trial of faecal occult blood testing for colorectal cancer: a 20-year follow-up.
Scholefield JH; Moss SM; Mangham CM; Whynes DK; Hardcastle JD
Gut; 2012 Jul; 61(7):1036-40. PubMed ID: 22052062
[TBL] [Abstract][Full Text] [Related]
3. Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer.
Lindholm E; Brevinge H; Haglind E
Br J Surg; 2008 Aug; 95(8):1029-36. PubMed ID: 18563785
[TBL] [Abstract][Full Text] [Related]
4. Early detection of colorectal cancer with faecal occult blood test screening.
Paimela H; Malila N; Palva T; Hakulinen T; Vertio H; Järvinen H
Br J Surg; 2010 Oct; 97(10):1567-71. PubMed ID: 20603855
[TBL] [Abstract][Full Text] [Related]
5. Faecal occult blood screening and reduction of colorectal cancer mortality: a case-control study.
Faivre J; Tazi MA; El Mrini T; Lejeune C; Benhamiche AM; Dassonville F
Br J Cancer; 1999 Feb; 79(3-4):680-3. PubMed ID: 10027349
[TBL] [Abstract][Full Text] [Related]
6. Survival of patients with colorectal cancer diagnosed in a randomized controlled trial of faecal occult blood screening.
Mapp TJ; Hardcastle JD; Moss SM; Robinson MH
Br J Surg; 1999 Oct; 86(10):1286-91. PubMed ID: 10540135
[TBL] [Abstract][Full Text] [Related]
7. Colorectal cancer screening using fecal occult blood test and subsequent risk of colorectal cancer: a prospective cohort study in Japan.
Lee KJ; Inoue M; Otani T; Iwasaki M; Sasazuki S; Tsugane S;
Cancer Detect Prev; 2007; 31(1):3-11. PubMed ID: 17289293
[TBL] [Abstract][Full Text] [Related]
8. Faecal occult blood screening for colorectal cancer at Nottingham: details of the verification process.
Robinson MH; Rodrigues VC; Hardcastle JD; Chamberlain JO; Mangham CM; Moss SM
J Med Screen; 2000; 7(2):97-8. PubMed ID: 11002450
[TBL] [Abstract][Full Text] [Related]
9. A 25-year follow-up of a population screened with faecal occult blood test in Finland.
Malila N; Hakama M; Pukkala E
Acta Oncol; 2007; 46(8):1103-6. PubMed ID: 17851857
[TBL] [Abstract][Full Text] [Related]
10. Screening for colorectal cancer: comparison of perceived test burden of guaiac-based faecal occult blood test, faecal immunochemical test and flexible sigmoidoscopy.
Hol L; de Jonge V; van Leerdam ME; van Ballegooijen M; Looman CW; van Vuuren AJ; Reijerink JC; Habbema JD; Essink-Bot ML; Kuipers EJ
Eur J Cancer; 2010 Jul; 46(11):2059-66. PubMed ID: 20621736
[TBL] [Abstract][Full Text] [Related]
11. Risk for colorectal cancer in elderly persons and possible methodologies for their screening.
Rozen P; Shabtai EI; Liphshitz I; Barchana M
Eur J Gastroenterol Hepatol; 2011 May; 23(5):431-7. PubMed ID: 21448071
[TBL] [Abstract][Full Text] [Related]
12. Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer (Br J Surg 2008; 95: 1029-1036).
Corder AP; Iqbal M; Devaraj S
Br J Surg; 2008 Nov; 95(11):1428-9; author reply 1429. PubMed ID: 18844282
[No Abstract] [Full Text] [Related]
13. [Faecal occult blood test and mass screening for colorectal cancer].
Hiwatashi N; Shimada T
Nihon Rinsho; 2003 Sep; 61 Suppl 7():201-6. PubMed ID: 14574882
[No Abstract] [Full Text] [Related]
14. Colonoscopy-controlled intra-individual comparisons to screen relevant neoplasia: faecal immunochemical test vs. guaiac-based faecal occult blood test.
Oort FA; Terhaar Sive Droste JS; Van Der Hulst RW; Van Heukelem HA; Loffeld RJ; Wesdorp IC; Van Wanrooij RL; De Baaij L; Mutsaers ER; van der Reijt S; Coupe VM; Berkhof J; Bouman AA; Meijer GA; Mulder CJ
Aliment Pharmacol Ther; 2010 Feb; 31(3):432-9. PubMed ID: 19878150
[TBL] [Abstract][Full Text] [Related]
15. Faecal occult blood test-based screening programme with high compliance for colonoscopy has a strong clinical impact on colorectal cancer.
Parente F; Marino B; DeVecchi N; Moretti R; ; Ucci G; Tricomi P; Armellino A; Redaelli L; Bargiggia S; Cristofori E; Masala E; Tortorella F; Gattinoni A; Odinolfi F; Pirola ME
Br J Surg; 2009 May; 96(5):533-40. PubMed ID: 19358181
[TBL] [Abstract][Full Text] [Related]
16. [Does yearly fecal exam for occult blood lower colorectal cancer mortality?].
Gerbes L; Jüngst D; Köbberling J
Z Gastroenterol; 1994 Oct; 32(10):603-6. PubMed ID: 7716998
[No Abstract] [Full Text] [Related]
17. Limitations of the faecal occult blood test in screening for colorectal cancer.
Delcò F; Sonnenberg A
Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):119-26. PubMed ID: 10363196
[TBL] [Abstract][Full Text] [Related]
18. Colorectal cancer screening in Europe: compliance and the choice of test.
Riemann JF
Endoscopy; 2010 Jul; 42(7):576-7. PubMed ID: 20593335
[No Abstract] [Full Text] [Related]
19. Analysis of deaths occurring within the Nottingham trial of faecal occult blood screening for colorectal cancer.
Oliphant R; McLoone P; Morrison D
Gut; 2011 Aug; 60(8):1163-4. PubMed ID: 21193450
[No Abstract] [Full Text] [Related]
20. Long-term mortality after screening for colorectal cancer.
Shaukat A; Mongin SJ; Geisser MS; Lederle FA; Bond JH; Mandel JS; Church TR
N Engl J Med; 2013 Sep; 369(12):1106-14. PubMed ID: 24047060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
